BIOMUNEX Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of breakthrough immunotherapies using its Unique BiXAb® technology to create next generation bi- and multi-specific antibodies.
Our disruptive biological approaches target a number of cancer types, in particular where there are unmet medical needs. We are committed to provide oncologists and patients with immunotherapies that are novel, efficacious and prolong life expectancy.
Company Details
- Employees
- 12
- Address
- 113 Rue De La Tour, Paris,75116,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.biomunex.com
- Keywords
- OSE Immunotherapeutics.
- HQ
- PARIS
Biomunex Pharmaceuticals Questions
Biomunex Pharmaceuticals's website is http://www.biomunex.com
Biomunex Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/biomunex-pharmaceuticals
Biomunex Pharmaceuticals has
12 employees.
View email and phone details for 12
employees at Biomunex Pharmaceuticals.
Biomunex Pharmaceuticals's industry is
Biotechnology Research
Biomunex Pharmaceuticals's top competitors are
Eligo Bioscience,
Mabdesign,
Astraveus,
Ose Immunotherapeutics,
Omen Partners,
Acticor Biotech,
Smart Immune,
Pep-Therapy,
Invectys,
Aenitis Technologies.
Biomunex Pharmaceuticals's categories are Biotechnology Research
